HBV Forum 4 was held in Paris, France at the Novotel Paris Pont Sevres Hotel on Thursday, April 12th, 2018.  The meeting was attended by 111 participants, 92 in person and 19 remotely.

Materials 

Agenda

List of participants

Evaluation Report

Meeting Summary

Presentations

Welcoming Remarks

Veronica Miller, William (Bill) Symonds and Pedro Goicochea

Roadmap on HBV at EASL 2018

Robert Gish

HBV Cure Initiatives in the AIDS Clinical Trials Group

Mark Sulkowski

Effects on Combination Therapy on Achieving Cure

Barbara Testoni

Modelling Kinetics of HBV DNA and Recommendations for Moving Forward

Alan Perelson

Expanding Immune Monitoring in HBV Trials - Part I 

Adam Gehring

Expanding Immune Monitoring in HBV Trials - Part II

Mala Maini

HBV Cure Roadmap: Follow-up from Hepatitis B Foundation Meetings with NIAID, NIDDK and NCI Regarding an NIH HBV Cure Agenda

Carol Brosgart

Community Perspectives on the Road to HBV Cure

Joan Block, Maureen Kamischke, Michael Ninburg and Su Wang

HBV Forum Liver Safety Monitoring sub-Working Group update

Robert Fontana and Maria Beumont-Mauviel